Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009, 2011
The production of clinical batches of cells for cell therapy poses a series of challenges that ar... more The production of clinical batches of cells for cell therapy poses a series of challenges that are related to the high degree of biological variability typical of the living organisms. Since a full characterization of every property of a cellular product is very difficult, it is mandatory to extensively characterize the process in order to generate a safe and effective product in a reproducible way. Here we describe a procedure for the production and quality control analysis of clinical batches of bone marrow-derived mesenchymal stem cells.
Bookmarks Related papers MentionsView impact
Uploads
Papers by Marta Galgano